- Home
- SHFS vs TENX Comparison
SHFS vs TENX Comparison
Compare SHFS & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHFS
- TENX
- Stock Information
- Founded
- SHFS 2015
- TENX 1967
- Country
- SHFS United States
- TENX United States
- Employees
- SHFS N/A
- TENX N/A
- Industry
- SHFS Finance: Consumer Services
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- SHFS Finance
- TENX Health Care
- Exchange
- SHFS Nasdaq
- TENX Nasdaq
- Market Cap
- SHFS 20.8M
- TENX 21.6M
- IPO Year
- SHFS N/A
- TENX N/A
- Fundamental
- Price
- SHFS $2.19
- TENX $6.17
- Analyst Decision
- SHFS
- TENX Strong Buy
- Analyst Count
- SHFS 0
- TENX 3
- Target Price
- SHFS N/A
- TENX $16.00
- AVG Volume (30 Days)
- SHFS 9.1K
- TENX 35.4K
- Earning Date
- SHFS 08-13-2025
- TENX 08-12-2025
- Dividend Yield
- SHFS N/A
- TENX N/A
- EPS Growth
- SHFS N/A
- TENX N/A
- EPS
- SHFS N/A
- TENX N/A
- Revenue
- SHFS $13,956,453.00
- TENX N/A
- Revenue This Year
- SHFS N/A
- TENX N/A
- Revenue Next Year
- SHFS N/A
- TENX N/A
- P/E Ratio
- SHFS N/A
- TENX N/A
- Revenue Growth
- SHFS N/A
- TENX N/A
- 52 Week Low
- SHFS $1.84
- TENX $2.80
- 52 Week High
- SHFS $14.86
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- SHFS 39.06
- TENX 51.83
- Support Level
- SHFS $2.14
- TENX $5.62
- Resistance Level
- SHFS $2.48
- TENX $6.35
- Average True Range (ATR)
- SHFS 0.14
- TENX 0.46
- MACD
- SHFS -0.01
- TENX 0.01
- Stochastic Oscillator
- SHFS 9.62
- TENX 41.49
About SHFS SHF Holdings Inc.
SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring among others.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.